arrow
O

Olszanski, Anthony

university of michigan system
H指数:0
被引数:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DELTA-1: A GLOBAL, MULTICENTER, PHASE 2 STUDY OF ITIL-168, AN UNRESTRICTED AUTOLOGOUS TUMORINFILTRATING LYMPHOCYTE (TIL) CELL THERAPY, IN ADULT PATIENTS WITH ADVANCED CUTANEOUS MELANOMA
2022-11-070
OA
FIRST-IN-HUMAN PHASE 1/2 STUDY OF THE FIRST-IN-CLASS SUMO-ACTIVATING ENZYME INHIBITOR TAK-981 IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS OR RELAPSED/REFRACTORY LYMPHOMA: PHASE 1 RESULTS

首次在晚期或转移性实体瘤或复发/难治性淋巴瘤患者中TAK-981 SUMO激活酶抑制剂的人类1/2期研究: 1期结果

2021-11-104
OA
FINAL ANALYSIS: PHASE 1B STUDY INVESTIGATING INTRATUMORAL INJECTION OF TOLL-LIKE RECEPTOR 9 AGONIST VIDUTOLIMOD ± PEMBROLIZUMAB IN PATIENTS WITH PD-1 BLOCKADE-REFRACTORY MELANOMA
2021-11-106
OA
PHASE I CLINICAL TRIAL EVALUATING THE SAFETY OF ADP-A2M10 SPEAR T-CELLS IN PATIENTS WITH MAGE-A10+ ADVANCED NON-SMALL CELL LUNG CANCER
2020-12-101
PREAI